Hematologic Malignancies

Mayo Clinic   

Questions discussed in this category



Do you utilize rituximab or any other specific management strategies?

Frailty Index per Palumbo et al. PMID 25628469Is it practical to apply in clinics? Have you made decision changes based on it?

CAR-T (any specific preference of product?) vs bispecific antibodies vs any other specific agents not previously utilized?


Papers discussed in this category


The New England journal of medicine, 2012-05-10

Nature communications, 2019-04-23

Blood, 2012 Aug 13

J Clin Oncol, 2020 Apr 16

Blood,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-10-10

The New England journal of medicine, 2017-04-06

The Lancet. Oncology, 2019-01

Blood,

Blood, 2015-03-26

Clin Lymphoma Myeloma Leuk, 2019 Oct 09

JCO Oncol Pract, 2019 Nov 25

Proc Natl Acad Sci U S A, 2019 Apr 15

N Engl J Med,

N Engl J Med,

Clin Lymphoma Myeloma Leuk, 2020 Jul 29

Br J Haematol, 2021 Aug 15

Blood, 2022 Dec 08

Leukemia, 2019-03

Leukemia, 2022 Feb 21

Lancet, 2021 Jun 24

N Engl J Med, 2023 Jun 05

N Engl J Med, 2023 Feb 10

Lancet Oncol, 2021 Dec 03

Lancet, 2021 Jun 04

Br J Haematol, 2023 Jun 07

J Clin Oncol, 2021 Aug 13

The Lancet. Haematology, 2023 Sep 11

The Lancet. Oncology, 2021 Sep 13

The New England journal of medicine, 2019-05-30

Blood, 2023 Nov 30

Cancer, 2011-10-01

BMC Cancer, 2006 May 05

International journal of radiation oncology, biology, physics, 1998-07-15

International journal of radiation oncology, biology, physics, 2006-01-01

Blood, 2014 May 29

Blood, 2014 Jun 17

International journal of radiation oncology, biology, physics, 2011 Jan 27